ANZU SPECIAL ACQUISITION -A (ANZU)

US03737A1016 - Common Stock

7.015  +1.38 (+24.38%)

After market: 7.02 +0 (+0.07%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ANZU SPECIAL ACQUISITION -A

NASDAQ:ANZU (9/29/2023, 7:17:40 PM)

After market: 7.02 +0 (+0.07%)

7.015

+1.38 (+24.38%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap104.80M
Shares
PE701.5
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

ANZU Daily chart

Company Profile

Anzu Special Acquisition Corp.I is a blank check company, which engages in forming for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Tampa, Florida. The company went IPO on 2021-03-02. The firm is created for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm focuses on transformative technologies for industrial applications. The firm has no operations and has not generated revenues.

Company Info

ANZU SPECIAL ACQUISITION -A

12610 Race Track Road, Suite 250

Tampa FLORIDA

P: 18139177733.0

Employees: 0

Website: https://anzuspac.com/

ANZU News

News Image7 months ago - Seeking AlphaEnvoy Medical shares sink 30% in market debut following SPAC merger (NASDAQ:ANZU)

Envoy Medical shares plummeted 30% in their market debut following the hearing device maker's merger with SPAC Anzu I. Read more here.

News Image7 months ago - Seeking AlphaSPAC Anzu I, Envoy Medical shareholders approve merger deal (ANZU)

SPAC Anzu and Envoy Medical shareholders have approved their merger deal, with shares of the combined company expected to begin trading on Oct. 2.

News Image7 months ago - Anzu Special Acquisition Corp IAnzu Special Acquisition Corp I Stockholders Approve Business Combination with Envoy Medical Corporation
News Imagea year ago - Anzu Special Acquisition Corp IAnzu Special Acquisition Corp I Announces Adjournment of Special Meeting of Stockholders

ANZU Twits

Here you can normally see the latest stock twits on ANZU, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example